These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8856294)

  • 41. Stevens-Johnson syndrome associated with bezafibrate.
    Sawamura D; Umeki K
    Acta Derm Venereol; 2000; 80(6):457. PubMed ID: 11243650
    [No Abstract]   [Full Text] [Related]  

  • 42. [Peritoneal dialysis in patients with polycystic kidneys].
    Pavlović NB; Stojacnov S; Ljubenović S; Krivokapić R
    Srp Arh Celok Lek; 1996; 124 Suppl 1():157-8. PubMed ID: 9102888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Morphometry of abnormal peroxisomes induced by withdrawal of bezafibrate, a hypolipidemic drug in male rat hepatocytes.
    Kondo K; Makita T
    J Vet Med Sci; 1997 Apr; 59(4):297-9. PubMed ID: 9152941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate.
    Olukoga AO
    J Clin Pathol; 2002 Sep; 55(9):718. PubMed ID: 12195008
    [No Abstract]   [Full Text] [Related]  

  • 45. [Severe rhabdomyolysis associated with cerivastatin and gemfibrozil].
    de Arriba Méndez JJ; Gómez Merino E; Sáez Barcelona JA; Sáez Méndez L
    Med Clin (Barc); 2001 Sep; 117(7):278-9. PubMed ID: 11562335
    [No Abstract]   [Full Text] [Related]  

  • 46. Rhabdomyolysis due to simvastatin in a transplant patient: Are some statins safer than others?
    Stirling CM; Isles CG
    Nephrol Dial Transplant; 2001 Apr; 16(4):873-4. PubMed ID: 11274299
    [No Abstract]   [Full Text] [Related]  

  • 47. A paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate.
    Crook MA; Lynas J; Wray R
    J Clin Pathol; 2000 Oct; 53(10):796-7. PubMed ID: 11064678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rhadbdomyolysis after coronary artery bypass grafting in a patient receiving simvastatin.
    Alvarez JM; Rawdanowicz TJ; Goldstein J
    J Thorac Cardiovasc Surg; 1998 Oct; 116(4):654-5. PubMed ID: 9766599
    [No Abstract]   [Full Text] [Related]  

  • 49. Fenofibrate-induced rhabdomyolysis in a patient with chronic kidney disease: an unusual presenting feature of hypothyroidism.
    Sousa AA; Kronit HS; Neves Fde A; Amato AA
    Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):383-6. PubMed ID: 19578603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fenofibrate monotherapy induced rhabdomyolysis.
    Barker BJ; Goodenough RR; Falko JM
    Diabetes Care; 2003 Aug; 26(8):2482-3. PubMed ID: 12882895
    [No Abstract]   [Full Text] [Related]  

  • 51. Indirect inguinal hernia in CAPD patients with polycystic kidney disease.
    Modi KB; Grant AC; Garret A; Rodger RS
    Adv Perit Dial; 1989; 5():84-6. PubMed ID: 2577435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.
    Matzno S; Tazuya-Murayama K; Tanaka H; Yasuda S; Mishima M; Uchida T; Nakabayashi T; Matsuyama K
    J Pharm Pharmacol; 2003 Jun; 55(6):795-802. PubMed ID: 12841940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful pregnancy in a patient treated with continuous ambulatory peritoneal dialysis.
    Bennett-Jones DN; Aber GM; Baker K
    Nephrol Dial Transplant; 1989; 4(6):583-5. PubMed ID: 2507983
    [No Abstract]   [Full Text] [Related]  

  • 54. [Antilipemic agents, hypothyroidism, and rhabdomyolysis].
    Pía Iglesias G; Garrido Sanjuán JA; González González C; Sesma Sánchez P
    Rev Clin Esp; 2000 Apr; 200(4):236-7. PubMed ID: 10857417
    [No Abstract]   [Full Text] [Related]  

  • 55. [Rhabdomyolysis induced by fenofibrate monotherapy].
    Archambeaud-Mouveroux F; Lopez S; Combes C; Lassandre S; Amaniou M; Teissier MP; Galinat S
    Rev Med Interne; 2006 Jul; 27(7):573-4. PubMed ID: 16716459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bezafibrate retard in type II diabetic patients: effects on hemostasis and glucose homeostasis.
    Mikhailidis DP; Mathur S; Barradas MA; Dandona P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 9():platelet inhib/pd/ad/ae. PubMed ID: 1710742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Rhabdomyolysis associated with the use of simvastatin].
    Pinilla Moraza J; Fernández Requena E; Cortes Bejar M; Khalil H
    Rev Clin Esp; 2003 Dec; 203(12):615. PubMed ID: 14622517
    [No Abstract]   [Full Text] [Related]  

  • 58. Acute renal failure due to fenofibrate monotherapy.
    Usküdar Cansu D; Yaşar NS; Korkmaz C
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):371-2. PubMed ID: 21592934
    [No Abstract]   [Full Text] [Related]  

  • 59. Fenofibrate-induced rhabdomyolysis in a patient with stage 4 chronic renal failure due to diabetes mellitus.
    Soyoral YU; Canbaz ET; Erdur MF; Emre H; Begenik H; Erkoc R
    J Pak Med Assoc; 2012 Aug; 62(8):849-51. PubMed ID: 23862266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Gemfibrozil induced rhabdomyolysis in a patient with undiscovered hypothyroidism].
    Barquero-Romero J; Rodríguez Vázquez C; Arrobas Vacas I
    An Med Interna; 2006 Oct; 23(10):504-5. PubMed ID: 17205640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.